PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 11, 2026Critical Reviews in Analytical Chemistry0 citations

Matrix Effects and Analytical Instability in Pharmaceutical Bioanalysis: Current Challenges and Future Directions

View Full Paper
HBHemn A.H. BarzaniRORebaz Anwar OmerNANergz Bayiz Abdulrahman

Key Points

  • This review evaluates the impact of matrix effects and analyte instability on pharmaceutical bioanalysis and explores solutions for improving analytical performance.
  • Critical evaluation of mechanistic basis for matrix effects and instability
  • Discussion of advanced sample preparation strategies like selective SPE and microextraction
  • Highlighting the role of AI and modern LC-MS technologies in bioanalysis
  • Identified complex biological matrices as a major source of analytical challenges
  • Advanced sample preparation methods significantly enhance trace-level analysis
  • AI-assisted workflows are revolutionizing pharmaceutical bioanalysis towards smart ecosystems

Abstract

Pharmaceutical bioanalysis plays a central role in drug development, therapeutic drug monitoring, pharmacokinetics, metabolomics, and clinical diagnostics; however, the increasing complexity of biological and pharmaceutical matrices has created major analytical challenges related to matrix effects and analyte instability. Endogenous compounds such as phospholipids, proteins, salts, metabolites, and formulation excipients can interfere with chromatographic separation and electrospray ionization, leading to ion suppression or enhancement, signal fluctuations, reduced sensitivity, and compromised quantitative accuracy. In addition, hydrolysis, oxidation, photodegradation, enzymatic degradation, and adsorption processes can significantly affect analyte stability during sample collection, storage, preparation, and LC-MS analysis. This review critically evaluates the mechanistic basis of matrix effects and analytical instability in pharmaceutical bioanalysis and highlights recent advances in intelligent analytical technologies designed to improve analytical robustness, reproducibility, and sustainability. Advanced sample preparation strategies, including selective SPE, phospholipid-removal systems, MIP, and microextraction technologies, together with modern LC-MS platforms such as UHPLC-MS/MS and HRMS, have significantly enhanced trace-level pharmaceutical analysis in complex matrices. Furthermore, artificial intelligence-assisted workflows, microfluidics, biosensors, and omics-based analytical systems are transforming pharmaceutical bioanalysis toward automated and smart analytical ecosystems. Future pharmaceutical bioanalysis is expected to integrate intelligent, sustainable, and highly automated analytical systems that combine AI-driven analytics, advanced LC-MS technologies, green and white analytical chemistry principles, and harmonized regulatory frameworks to improve clinical applicability, analytical reliability, and environmental sustainability.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Barzani et al. (2026) studied this question.

synapsesocial.com/papers/6a51df22c18d7f28ca5007c9https://doi.org/10.1080/10408347.2026.2698067
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Biopharmaceutical analysis — current analytical challenges, limitations, and perspectives2025
  2. 2Evolving bioanalytical strategies in the wake of pioneering biotherapeutics2025
  3. 3ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN PHARMACEUTICAL ANALYSIS: RECENT ADVANCES IN METHOD DEVELOPMENT AND DATA INTERPRETATION2026
  4. 4Review on Bio- Analytical Chemistry: A Key to Understanding Biological Molecules2025
  5. 5Artificial intelligence assisted pharmaceutical analysis for sustainable quality monitoring and continuous manufacturing applications2026